Johnson & Johnson Coronavirus Vaccine Wins FDA Authorization

Eric Volkman, The Motley Fool
·2-min read
Johnson & Johnson Coronavirus Vaccine Wins FDA Authorization

Johnson & Johnson's (NYSE: JNJ) vaccine, developed by its subsidiary Janssen, received Emergency Use Authorization (EUA) from the FDA on Saturday. This followed a unanimous vote by the regulator's vaccines and related biological products advisory committee that it do so. In contrast to the two shots required for both of the other FDA-authorized coronavirus vaccines -- Moderna's (NASDAQ: MRNA) mRNA-1273 and Pfizer (NYSE: PFE) and BioNTech's (NASDAQ: BNTX) BNT162b2 -- Johnson & Johnson's is a one-shot inoculation.